Centiva Capital LP Makes New Investment in Schrödinger, Inc. (NASDAQ:SDGR)

Centiva Capital LP acquired a new position in shares of Schrödinger, Inc. (NASDAQ:SDGR) in the 4th quarter, Holdings Channel.com reports. The firm acquired 18,307 shares of the company’s stock, valued at approximately $353,000.

Several other hedge funds have also recently bought and sold shares of SDGR. Sumitomo Mitsui Trust Group Inc. lifted its position in Schrödinger by 60.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,510,518 shares of the company’s stock worth $67,718,000 after acquiring an additional 1,319,464 shares during the last quarter. Nikko Asset Management Americas Inc. lifted its holdings in shares of Schrödinger by 108.7% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 2,464,911 shares of the company’s stock worth $47,499,000 after acquiring an additional 1,283,949 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in shares of Schrödinger by 17.2% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,279,313 shares of the company’s stock worth $43,968,000 after acquiring an additional 334,131 shares during the period. Natixis bought a new stake in shares of Schrödinger during the 4th quarter worth approximately $1,750,000. Finally, Barclays PLC lifted its holdings in shares of Schrödinger by 421.6% during the 3rd quarter. Barclays PLC now owns 107,554 shares of the company’s stock worth $1,995,000 after acquiring an additional 86,933 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Karen Akinsanya sold 16,723 shares of the firm’s stock in a transaction on Monday, April 14th. The shares were sold at an average price of $25.09, for a total transaction of $419,580.07. Following the completion of the transaction, the insider now owns 15,625 shares of the company’s stock, valued at approximately $392,031.25. This trade represents a 51.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Geoffrey Craig Porges sold 5,491 shares of the firm’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $21.76, for a total transaction of $119,484.16. Following the transaction, the chief financial officer now directly owns 27,544 shares of the company’s stock, valued at $599,357.44. The trade was a 16.62% decrease in their position. The disclosure for this sale can be found here. Insiders own 8.60% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on SDGR. KeyCorp raised their target price on shares of Schrödinger from $30.00 to $32.00 and gave the company an “overweight” rating in a research report on Wednesday, April 16th. Piper Sandler cut their target price on shares of Schrödinger from $50.00 to $45.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $32.80.

Schrödinger Stock Performance

SDGR stock opened at $23.90 on Monday. The company has a fifty day moving average price of $22.62 and a 200-day moving average price of $21.82. The company has a market capitalization of $1.75 billion, a P/E ratio of -10.21 and a beta of 1.84. Schrödinger, Inc. has a 52-week low of $16.60 and a 52-week high of $28.47.

Schrödinger (NASDAQ:SDGR) last released its quarterly earnings results on Wednesday, May 7th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by ($0.01). The business had revenue of $59.55 million for the quarter, compared to the consensus estimate of $54.60 million. Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. Schrödinger’s revenue was up 62.7% on a year-over-year basis. During the same period in the previous year, the business posted ($0.86) EPS. As a group, sell-side analysts forecast that Schrödinger, Inc. will post -2.37 earnings per share for the current fiscal year.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.